Cryptococcus neoformans is unique among the pathogenic fungi in that it has a polysaccharide capsule which is a major virulence factor (15) . Structural differences in the capsular polysaccharide result in antigenic differences that have been used to classify strains into four serotypes, known as A, B, C, and D (6) . C. neoformans strains have also been classified into two varieties on the basis of several genetic and biochemical differences. C. neoformans var. neoformans comprises serotypes A and D, whereas C. neoformans var. gattii comprises serotypes B and C. The serotype classification for C. neoformans was originally developed in the 1940s by using reciprocally absorbed rabbit immune sera (11, 12) . The usefulness of the serotype classification scheme has been limited by the fact that most var. neoformans strains have been grouped as serotype A, despite considerable evidence for structural variation in the glucuronoxylomannan (GXM) of strains assigned to this serotype (21) . The relationship between serotype A and D strains is uncertain. Detailed structures for the GXMs of all of the serotypes have been proposed, but the molecular structures responsible for the antigenic differences which allow classification into particular serotypes are not understood (6) .
Monoclonal antibody (MAb) technology provides a potential alternative to rabbit sera for generating reagents for the study of the antigenic composition of the capsule. Several groups have generated MAbs to the capsular polysaccharide of C. neoformans (1, 2, 4, 10, 14, 21, 22) . Unfortunately, most of the MAbs studied to date are not specific for a given serotype (1) . An exception is MAb E1, which binds distinctly to serotype A strains and can be useful for classifying strains (9) . Recently, a MAb with specificity for serotype D strains has been described (14) . The availability of MAbs that can consistently discriminate between C. neoformans var. neoformans strains may assist in the study of capsular structure.
Previously, we reported that two immunoglobulin M (IgM) MAbs derived from the same progenitor B cell bound to spatially different epitopes on the C. neoformans capsule (17, 20) . In this study, we evaluated the binding of these MAbs to a larger set of well-characterized strains and correlated immunofluorescence (IF) binding patterns with agglutination, phagocytosis, and flow cytometry studies. The results indicate that IF patterns correlate with serotype classification and other serological assays.
(The data in this report are from a thesis to be submitted by W. Cleare in partial fulfillment of the requirements for the degree of doctor of philosophy at the Sue Golding Graduate Division of Medical Science, Albert Einstein College of Medicine, Yeshiva University, Bronx, N.Y.)
MATERIALS AND METHODS
Strains. C. neoformans 24067, 34874, 28958, 34873, and 34870 were obtained from the American Type Culture Collection (Rockville, Md.). Strains J11A, SB4, SB6, J22, and J9A were isolated from patients with cryptococcal meningitis in New York City. Strains CN 6, CN 15, CN 98, CN 110, and CN 145 were provided by Stuart Levitz (Boston, Mass.); 184A was provided by Juneanne Murphy (Oklahoma City, Okla.). Strains 371, 62066, and H99 were obtained from J. E. Bennett (National Institutes of Health, Bethesda, Md.), Robert Cherniak (Atlanta, Ga.), and John Perfect (Durham, N.C.), respectively. The serotype classification of the strains listed in Table 1 was derived by classical rabbit serological methods or typed by nuclear magnetic resonance analysis, and the serotype assignment was confirmed by serology. Twenty-two additional C. neoformans var. neoformans isolates (9 serotype A and 13 serotype D) for blind IF analysis were provided by Mary Brandt (Atlanta, Ga.). All strains were maintained on Sabouraud dextrose agar slants (Difco Laboratories, Detroit, Mich.) at 4°C and grown in Sabouraud dextrose broth (Difco) at 30°C prior to use.
MAbs. MAbs 12A1 and 13F1 have already been described (2, 17, 20) . Both are IgM and were generated from splenocytes of BALB/c mice immunized with the GXM-tetanus toxoid vaccine. Ascitic fluid containing hybridoma protein was generated by injecting 10 7 hybridoma cells into the peritoneal cavities of pristane-primed BALB/c mice and obtaining the fluid by paracentesis. Antibody concentration was determined by enzyme-linked immunosorbent assay relative to isotype-matched standards. For phagocytosis experiments, the antibodies were purified by mannose protein affinity chromatography in accordance with the manufacturer's (Pierce, Rockford, Ill.) instructions.
Indirect IF. Stationary-phase (3 to 5 days) yeast cells were washed three times in phosphate-buffered saline (PBS; 0.137 M NaCl, 0.003 M sodium phosphate, pH 7.4), and 10 6 cells were placed into microcentrifuge tubes (liquid method) or mounted onto poly-L-lysine-coated slides (Sigma, St. Louis, Mo.) (dry method). MAb (10 g/ml) was added to cryptococcal cells, and the mixture was incubated for 2 h at room temperature. Yeast cells were washed with PBS and incubated with 10 g of fluorescein isothiocyanate (FITC)-labeled goat anti-mouse IgM (Southern Biotechnology, Birmingham, Ala.) per ml for 1 h at room temperature in the dark. Cells were washed again with PBS and suspended in 50 l of mounting medium consisting of a solution of 50% glycerol-0.1 M n-propyl gallate (Sigma) in PBS. The cells were mounted on glass slides and viewed with an Axiophot microscope (Zeiss, Thornwood, N.Y.) equipped with an FITC filter. Confocal microscopy was performed with an MRC 600 laser scanning confocal microscope (Bio-Rad, Hercules, Calif.). Single optical sections were collected at a magnification of ϫ4 with Nikon 60ϫN.A. 1.4 phase 4 optics.
Agglutination assay. Agglutination assays were done with 96-well microtiter plates by using a modification of previously described protocols (7) . Briefly, serial dilutions of MAb which corresponded to MAb concentrations of 500 to 0.0019 g/ml in a solution of 75 mM NaCl-10 mM sodium phosphate buffer (pH 7.2)-0.5% bovine serum albumin-1 mM azide were done in 96-well polystyrene microtiter plates (no. 25801-96; Corning Glass Works, Corning, N.Y.). Approximately 5 ϫ 10 4 yeast cells were added to each well. The plate was shaken for 15 min on a rotating platform (Eberbach Corp., Ann Arbor, Mich.) at moderate speed and incubated without shaking at 4°C overnight. Agglutination occurred rapidly, but the endpoint was read after overnight incubation because this resulted in more reproducible measurements. The agglutination endpoint was the highest dilution of MAb at which agglutination was observed.
Phagocytosis assay. The J774.16 macrophage cell line originated from a murine reticulum cell sarcoma (8) and was used to study the opsonic efficacy of these MAbs for a selected set of strains as previously described (7) 16 monolayer in a macrophage-to-yeast ratio of 1:1 with either 20% fresh mouse serum, 20% heat-inactivated mouse serum, or MAb 12A1 or 13F1. Serum was obtained from BALB/c mice immediately before the assay. Whole blood was separated from serum by centrifugation. The serum used was either heat inactivated (56°C for 30 min) or fresh. The suspension was incubated for 2 h at 37°C. The J774.16 cell monolayer was then washed several times with PBS to remove nonadherent organisms, fixed with cold methanol, and stained with Giemsa (Sigma). The phagocytic index (PI) is the number of internalized yeast cells per number of macrophages per field. Internalized cells were differentiated from attached cells by their presence in a well-defined phagocytic vacuole. Previous studies using Uvitex B fluorescence staining have shown that one can easily discriminate between attached and internalized C. neoformans by microscopic examination of Giemsa-stained cultures (18, 19) . PIs were determined by light microscopy (Nikon Diaphot; Nikon, Inc., Instrument Division, Garden City, N.J.) at a magnification of ϫ600. (17, 20) . These results indicate a statistically significant difference in the ability of MAb 13F1 to produce annular or punctate IF patterns on serotype A and D strains, respectively (P Յ 0.001 by either chi square or Fisher exact test analysis). To determine whether the IF pattern was affected by the method used to prepare the sample, we compared the pattern obtained with cells suspended in liquid versus that obtained with cells attached to a slide by drying for five strains. Both methods produced consistent results. To determine if the MAb 13F1 IF pattern was dependent on the age of the culture, we analyzed IF patterns for the log (24-h) and stationary (72-h) growth phases of five strains. The same IF pattern was observed for both growth phases. Agglutination studies. Addition of MAbs 12A1 and 13F1 to each of the C. neoformans strains listed in Table 1 produced cell agglutination, but there were significant differences in the antibody concentration required for agglutination to occur. For strains with annular binding by MAb 12A1, the agglutination endpoints ranged from 0.24 to 7.8 g/ml (geometric mean of 1.6 g/ml). For strains with annular binding by MAb 13F1, the agglutination endpoints ranged from 0.49 to 62.5 g/ml (geometric mean of 5.7 g/ml). For strains with punctate binding by MAb 13F1, the agglutination endpoints ranged from 15.6 to 62.5 g/ml (geometric mean of 31.2 g/ml). Hence, C. neoformans agglutination required significantly higher concentrations of MAb 13F1 than MAb 12A1 and punctate binding was associated with higher agglutination endpoints (P Յ 0.05).
RESULTS

Indirect
Phagocytosis assay. The PI was measured as the number of internalized C. neoformans cells divided by the number of macrophages. The PIs for six of the strains with MAbs 12A1 and 13F1 were determined. There were significant strain differences in the ability of MAbs 12A1 and 13F1 to promote ingestion, as well as differences in the ability of MAbs 12A1 and 13F1 to promote ingestion for a given strain. For all strains, the addition of MAb 12A1 to J774.16 and C. neoformans suspensions resulted in a higher PI than that measured for MAb 13F1 (Fig. 1) .
The effect of complement on MAb 12A1-and 13F1-mediated phagocytosis was studied with strain 24067 (Fig. 2) . This strain was selected because it demonstrates the prototypical annular and punctate binding with MAbs 12A1 and 13F1, respectively. In the presence of complement, PI was significantly higher for all measurements. Hence, addition of complement produced quantitative changes in the opsonization of strain 24067 whether or not MAb 12A1 or 13F1 was present.
Flow cytometry. The patterns of MAb 12A1 and 13F1 binding to five strains was analyzed by FACS (Fig. 3) . For all strains, there was considerable cell-to-cell variation in fluorescence intensity. For all strains, the fluorescence intensity observed with MAb 12A1 was higher than that observed with MAb 13F1 (Table 2) . Punctate binding by MAb 13F1 produced the lowest fluorescence intensities observed among the samples studied.
Reproducibility and consistency of measurements. IF and FACS studies were done multiple times for some strains on different days, and the results were always consistent. Relative fluorescence intensities with MAbs 12A1 and 13F1 were measured by FACS at least seven times on different days. For all measurements, the intensity observed with MAb 12A1 was greater than that observed with MAb 13F1. Agglutination endpoints were measured for several strains on different days, and the endpoints were always within 1 dilution.
DISCUSSION
IgM MAbs 12A1 and 13F1 are closely related in molecular structure but differ in epitope specificity, as established by differences in serotype reactivity (3), competition assays (16) VOL. 5, 1998 PATTERNS OF MAb BINDING TO C. NEOFORMANS SEROTYPESand differences in binding to peptide mimetopes (23 One exception to the expected punctate binding by MAb 13F1 on serotype D strains was J22. This strain is unusual in that it has a novel GXM triad structure (5) . Whether this characteristic contributed to the unusual 13F1 binding pattern relative to other serotype D strains is unclear. The finding of the J22 exception to the association between MAb 13F1 punctate binding and a serotype D classification has several possible explanations. First, J22 may not be a classical serotype D strain, as suggested by its unusual GXM triad structure. Second, different antigenic determinants may be responsible for MAb 13F1 binding and serotype classification based on rabbit sera. In this scenario, serotype classification could be associated with a pattern of MAb 13F1 binding but each phenomenon could depend on different GXM structural components. Alternatively, the same antigenic determinants could be recognized by MAb 13F1 and the rabbit serotype-specific sera but structural heterogeneity in GXM could result in occasional strains that exhibit unusual serological characteristics. We cannot distinguish between these possibilities.
Previous IF studies of the binding of other MAbs to C. neoformans var. neoformans strains have reported annular patterns with serotype A and D organisms. MAb 13F1 is unusual in that it produces punctate IF on most serotype D strains. The physical basis for the punctate pattern is unknown. The IF pattern results from fluorescence emitted by the secondary antibody, which is labeled with fluorescein. One possibility is that the epitope recognized by 13F1 is found in discrete regions of the capsule. Alternatively, MAb 13F1 may bind in a manner that allows cross-linking of MAb 13F1 molecules by the secondary antibody with the result that aggregates form in the capsule. In any case, the IF differences in MAb 12A1 and 13F1 patterns indicate binding to different epitopes and also imply differences in epitope location in the capsule structure. This observation is consistent with and supports the report by Vogel in 1966 that specific antigens differ in location among strains, depending on the serotype classification (24) .
To determine whether the IF binding phenomena observed with MAbs 12A1 and 13F1 correlate with other serological techniques, additional studies were done with agglutination and FACS assays. Punctate binding by MAb 13F1 was associated with a requirement for a higher antibody concentration to produce agglutination. This suggests that epitopes which elicit punctate IF binding are relatively infrequent in the surface of the capsule and/or that the interaction between the MAb and this type of antigenic determinant is weak. Since the apparent affinities of MAbs 12A1 and 13F1 for GXM are very similar (16) , it is likely that the higher agglutination endpoints for punctate binding reflect a difference in epitope distribution. FACS revealed that MAb 13F1 produced a lower mean cell fluorescence intensity than MAb 12A1. Furthermore, punctate binding produced a lower mean cell fluorescence intensity than annular binding. Since the affinities of MAbs 12A1 and 13F1 for GXM are similar (16) and the affinity of the secondary, FITC-labeled reagent for each IgM should be the same, these results suggest that the epitope recognized by MAb 13F1 is found at either a lower density or in a different distribution in the capsule. Other explanations for the lower fluorescence intensity include lower epitope accessibility for MAb 13F1 or the secondary antibody. FACS analysis revealed considerable variation in the fluorescence intensities of individual cells for all of the strains studied. This variation was surprising since we used cultures derived from single colonies grown to early stationary phase. This variation in individual cell IF intensity presumably implies cell-to-cell differences in epitope density and/or content.
To determine if the differences in binding between MAbs 12A1 and 13F1 correlate with a functional effect, we studied the ability of these antibodies to promote phagocytosis of C. neoformans by J774.16 murine macrophage-like cells. Phagocytosis assays revealed that the annular binding pattern was associated with more effective opsonization than the punctate binding pattern. Furthermore, MAb 12A1 was a more effective opsonin than MAb 13F1 for all of the strains studied, irrespective of the IF binding pattern. The differences in phagocytic efficacy between MAbs 12A1 and 13F1 may reflect differences in epitope distribution as described for other systems (13) .
The epitopes recognized by MAbs 12A1 and 13F1 were found in all of the C. neoformans var. neoformans strains studied. The observation that MAb 13F1 discriminates between most serotype A and D strains provides strong support for the present serotype classification scheme devised with rabbit sera. MAb 13F1 binding to serotype A and D strains revealed differences in IF pattern and intensity, strongly suggesting that the antigenic differences between these serotypes are both qualitative and quantitative. In this regard, MAb 13F1 differs from the other MAbs used in serotyping schemes, which discriminate between serotype A and D strains solely on the basis of quantitative differences in binding.
In summary, we have demonstrated an association between the IF binding patterns of two IgM MAbs and the serotype classification of C. neoformans. Determination of whether the association is causal must await structural information about the epitopes recognized by these MAbs and the polysaccharide structures responsible for serotype classification. Our results suggest that this MAb pair may be useful for serological studies of C. neoformans strains. The results highlight the structural complexity of the capsule, the antigenic heterogeneity of C. neoformans strains, and the usefulness of MAbs in serological studies.
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